BioCryst Pharmaceuticals, Inc. (BCRX) Posts Q4 Loss of 22c/Share

February 19, 2013 6:14 AM

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) reported Q4 EPS of ($0.22) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found